Reports
Sale
United States Healthcare Advertising Market Size, Analysis: By Product Type: Pharmaceuticals (Small Molecule Drugs) Advertising Market, Biopharmaceuticals Market, Vaccines Market, Over-the-Counter Drugs Market, Others; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; 2024-2032
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 United States Healthcare Advertising Market Snapshot
7 Opportunities and Challenges in the Market
7.1 What Drives the Healthcare Advertising Market in the US?
7.1.1 Digitalization and other Technological Advancements
7.1.2 Increasing Presence of Generic and Me-too Drugs
7.1.3 Government Regulations Supporting DTC Advertising
7.1.4 Launch of New Drugs
7.1.5 Increased Consumer Reach through Mobile Advertising
7.1.6 Other Key Drivers
7.2 Market Challenges
7.2.1 Trust Gap between Consumers and Advertisers
7.2.2 Strict Rules and Regulations by FDA
7.2.3 Unethical Practices
7.2.4 Macroeconomic Scenario
7.2.5 Other Challenges
8 United States Healthcare Advertising Market Analysis
8.1 Key Industry Highlights
8.2 United States Healthcare Advertising Historical Market (2018-2023)
8.3 United States Healthcare Advertising Market Forecast (2024-2032)
8.4 United States Healthcare Advertising Market by Product Type
8.4.1 Pharmaceuticals (Small Molecule Drugs) Advertising Market
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Advertising Channel
8.4.1.4 Advertising Spend by Key Players
8.4.2 Biopharmaceuticals Market
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.2.3 Breakup by Advertising Channel
8.4.2.4 Advertising Spend by Key Players
8.4.3 Vaccines Market
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.3.3 Breakup by Advertising Channel
8.4.3.4 Advertising Spend by Key Players
8.4.4 Over-the-Counter Drugs Market
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.4.3 Breakup by Advertising Channel
8.4.4.4 Advertising Spend by Key Players
8.4.5 Others
9 Current Trends in Healthcare Advertising
9.1 Focus on Content
9.2 Rise of Multichannel Marketing
9.3 Targeting Consumers with Local Advertising
9.4 Reliance on Social Media
9.5 Surging Mobile Marketing
9.6 Consumers Becoming Researchers
9.7 Information Dispensed through Videos
9.8 Increasing Importance of Online Reviews
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Market Challenges
13 Competitive Landscape
13.1 Market Structure
13.2 Company Profiles
13.2.1 Johnson & Johnson Services, Inc
13.2.1.1 Company Overview
13.2.1.2 Financial Summary
13.2.1.3 Advertising Spend by Channel
13.2.1.4 Global Sales and Advertising Spend
13.2.1.5 Certifications
13.2.2 Pfizer Inc
13.2.2.1 Company Overview
13.2.2.2 Financial Summary
13.2.2.3 Advertising Spend by Channel
13.2.2.4 Global Sales and Advertising Spend
13.2.2.5 Certifications
13.2.3 Merck & Co., Inc
13.2.3.1 Company Overview
13.2.3.2 Financial Summary
13.2.3.3 Advertising Spend by Channel
13.2.3.4 Global Sales and Advertising Spend
13.2.3.5 Certifications
13.2.4 GlaxoSmithKline plc.
13.2.4.1 Company Overview
13.2.4.2 Financial Summary
13.2.4.3 Advertising Spend by Channel
13.2.4.4 Global Sales and Advertising Spend
13.2.4.5 Certifications
13.2.5 Eli Lilly and Company
13.2.5.1 Company Overview
13.2.5.2 Financial Summary
13.2.5.3 Advertising Spend by Channel
13.2.5.4 Global Sales and Advertising Spend
13.2.5.5 Certifications
13.2.6 Novartis AG
13.2.6.1 Company Overview
13.2.6.2 Financial Summary
13.2.6.3 Advertising Spend by Channel
13.2.6.4 Global Sales and Advertising Spend
13.2.6.5 Certifications
13.2.7 Sanofi-Aventis U.S. LLC
13.2.7.1 Company Overview
13.2.7.2 Financial Summary
13.2.7.3 Advertising Spend by Channel
13.2.7.4 Global Sales and Advertising Spend
13.2.7.5 Certifications
13.2.8 AstraZeneca
13.2.8.1 Company Overview
13.2.8.2 Financial Summary
13.2.8.3 Advertising Spend by Channel
13.2.8.4 Global Sales and Advertising Spend
13.2.8.5 Certifications
13.2.9 F. Hoffmann-La Roche Ltd
13.2.9.1 Company Overview
13.2.9.2 Financial Summary
13.2.9.3 Advertising Spend by Channel
13.2.9.4 Global Sales and Advertising Spend
13.2.9.5 Certifications
13.2.10 Bayer AG
13.2.10.1 Company Overview
13.2.10.2 Financial Summary
13.2.10.3 Advertising Spend by Channel
13.2.10.4 Global Sales and Advertising Spend
13.2.10.5 Certifications
13.2.11 Bristol-Myers Squibb Company
13.2.11.1 Company Overview
13.2.11.2 Financial Summary
13.2.11.3 Advertising Spend by Channel
13.2.11.4 Global Sales and Advertising Spend
13.2.11.5 Certifications
13.2.12 Others
14 Key Trends and Developments in the Market
List of Key Figures and Tables
1. United States Healthcare Advertising Market: Key Industry Highlights, 2018 and 2032
2. United States Healthcare Advertising Historical Market: Breakup by Product Type (USD Billion), 2018-2023
3. United States Healthcare Advertising Market Forecast: Breakup by Product Type (USD Billion), 2024-2032
4. United States Generic Drug Market Structure
Key Questions Answered in the Report
In 2023, the healthcare advertising market in the United States attained a value of nearly USD 22.84 billion.
The market is projected to grow at a CAGR of 4% between 2024 and 2032.
The market is estimated to witness a moderate growth in the forecast period of 2024-2032 to reach around USD 29.11 billion by 2032.
The major drivers of the market are rising advertisements for drugs, growth opportunities offered to several pharmaceutical marketers, and the rising number of health-conscious consumers in the country.
The key trends guiding the growth of the market include the rise of multichannel marketing and targeting consumers with local advertising.
Pharmaceuticals (small molecule drugs) advertising market, biopharmaceuticals market, vaccines market, and over-the-counter drugs market are the various product types in the market.
In the United States, the goal of healthcare advertising is to increase awareness regarding specific health issues and conditions as well as about the availability of procedures and drugs in the country.
The major players in the United States healthcare advertising market are Johnson & Johnson Services, Inc, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others.
Analyst Review
The United States healthcare advertising market attained a value of USD 22.84 billion in 2023, driven by the rising advertisements of prescription drugs. Aided by the rise of multichannel marketing, the industry is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 4.00%. The healthcare advertising market in the United States is projected to reach USD 29.11 billion by 2032.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the pharmaceuticals (small molecule drugs) advertising market accounts for the leading share in the industry. The key players in the above industry include Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol- Myers Squibb Company, and others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Datasheet
$ 2199
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 3299
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 4399
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 5499
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER